[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.175.236. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 52
Citations 0
Letters
February 1, 2012

Prostate Cancer Risk and Vitamin E—Reply

Author Affiliations
 

Letters Section Editor: Jody W. Zylke, MD, Senior Editor.

Author Affiliation: Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio (kleine@ccf.org).

JAMA. 2012;307(5):453-454. doi:10.1001/jama.2012.56

In Reply: The correspondents both address the biological mechanisms underlying the results of SELECT. Dr Gaby raises an interesting hypothesis about the interaction between α- and γ-tocopherol, which the SELECT authors hope to address using the biorepository of plasma samples by measuring levels of the different forms of vitamin E at baseline and after intervention in a subset of participants. Dr Hoskote and colleagues hypothesize that the placebo used in SELECT may protect against prostate cancer. The vitamin E placebo used was composed of soybean oil, predominantly polyunsaturated fatty acids. To my knowledge, the effect of soybean oil on risk of prostate cancer has never been tested in humans.

First Page Preview View Large
First page PDF preview
First page PDF preview
×